Janus Henderson Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.2K | Sell |
35,253
-3,255,590
| -99% | -$7.96M | ﹤0.01% | 2398 |
|
|
2025
Q1 | $25M | Sell |
3,290,843
-713,196
| -18% | -$5.41M | 0.01% | 520 |
|
|
2024
Q4 | $50.3M | Buy |
4,004,039
+2,106,699
| +111% | +$26.5M | 0.03% | 388 |
|
|
2024
Q3 | $35.1M | Sell |
1,897,340
-1,021,738
| -35% | -$18.9M | 0.02% | 461 |
|
|
2024
Q2 | $62.8M | Buy |
2,919,078
+313,062
| +12% | +$6.74M | 0.03% | 336 |
|
|
2024
Q1 | $70.2M | Buy |
2,606,016
+1,656,111
| +174% | +$44.6M | 0.04% | 323 |
|
|
2023
Q4 | $28.4M | Buy |
949,905
+47,810
| +5% | +$1.43M | 0.02% | 478 |
|
|
2023
Q3 | $18.5M | Buy |
902,095
+874,999
| +3,229% | +$17.9M | 0.01% | 548 |
|
|
2023
Q2 | $538K | Buy |
27,096
+66
| +0.2% | +$1.31K | ﹤0.01% | 1933 |
|
|
2023
Q1 | $463K | Buy |
27,030
+13,380
| +98% | +$229K | ﹤0.01% | 2064 |
|
|
2022
Q4 | $267K | Buy |
+13,650
| New | +$267K | ﹤0.01% | 2024 |
|
|
2022
Q1 | – | Sell |
-15,957
| Closed | -$348K | – | 2696 |
|
|
2021
Q4 | $348K | Sell |
15,957
-1,213,541
| -99% | -$26.5M | ﹤0.01% | 2119 |
|
|
2021
Q3 | $36.8M | Sell |
1,229,498
-5,991
| -0.5% | -$179K | 0.02% | 641 |
|
|
2021
Q2 | $54.7M | Sell |
1,235,489
-5,827
| -0.5% | -$258K | 0.02% | 547 |
|
|
2021
Q1 | $55.1M | Sell |
1,241,316
-35,994
| -3% | -$1.6M | 0.03% | 519 |
|
|
2020
Q4 | $70M | Buy |
1,277,310
+1,199,043
| +1,532% | +$65.8M | 0.03% | 458 |
|
|
2020
Q3 | $1.79M | Buy |
78,267
+4,698
| +6% | +$107K | ﹤0.01% | 1071 |
|
|
2020
Q2 | $1.54M | Buy |
73,569
+5,579
| +8% | +$117K | ﹤0.01% | 1066 |
|
|
2020
Q1 | $948K | Buy |
+67,990
| New | +$948K | ﹤0.01% | 1106 |
|